Medicare Part D's $2,000 Cap Rises to $2,100 for 2026

Medicare Part D's Out-of-Pocket Cap Rises to $2,100 for 2026

The $2,000 cap on what you pay out of pocket for covered Medicare Part D prescription drugs applied for 2025, its first year in effect under federal law. For 2026, the Centers for Medicare & Medicaid Services (CMS), the federal agency that runs Medicare, raised that cap to $2,100. The increase follows the annual inflation adjustment built into the Inflation Reduction Act of 2022, the law that created the hard dollar cap on Part D spending. If you take brand-name or specialty drugs, this change affects how much you'll pay before your plan covers 100% of your covered prescriptions for the rest of the year.

How the $2,100 Cap Works in 2026

Every Medicare Part D plan in 2026 follows the same basic spending structure, even though premiums and covered drug lists vary by plan. You move through up to three phases based on what you've spent on covered drugs so far this year:

• Deductible phase: CMS set the standard 2026 Part D deductible at $615, up from $590 in 2025. Not every plan charges the full deductible, and some plans waive it for certain drug tiers.
• Initial coverage phase: After you meet the deductible, you typically pay coinsurance or a copay set by your plan until your total out-of-pocket spending reaches the cap.
• Catastrophic phase: Once your out-of-pocket spending on covered drugs hits $2,100 in 2026, you pay nothing for the rest of the year for drugs on your plan's formulary.

This structure replaced the old "donut hole" coverage gap, which required people to pay a larger share of drug costs mid-year before catastrophic coverage kicked in. Under the current design, the Medicare.gov Part D cost structure caps what you owe regardless of how expensive your prescriptions are during the year.

What Counts Toward the Cap, and What Doesn't

Only your cost sharing for drugs covered by your plan's formulary counts toward the $2,100 cap in 2026. Your monthly Part D premium does not count, no matter how high it is. If you take a drug your plan doesn't cover and you don't get a formulary exception approved, that spending doesn't count toward the cap either. This is one reason it matters to confirm your plan's drug list each year during open enrollment, rather than assuming last year's coverage carries over unchanged.

The cap also interacts with other Medicare costs you may already be tracking. It's separate from the Medicare Advantage out-of-pocket maximum, which limits spending on medical services rather than drugs, and it's unrelated to Medicare IRMAA, the income-based surcharge added to Part B and Part D premiums for higher earners. If your Part D premium jumped this year because of income, that's a separate issue from the $2,100 cap, and you can look into whether an IRMAA appeal applies if your income has since dropped.

You Can Spread Your Costs Out Monthly

If reaching the $2,100 cap early in the year would strain your budget, the Medicare Prescription Payment Plan lets you spread your out-of-pocket drug costs across monthly installments for the rest of the plan year instead of paying the full amount at the pharmacy counter. This option, available since 2025 and continuing in 2026, is voluntary, free to join, and doesn't lower your total costs. It simply changes when you pay. It tends to help most if you fill an expensive prescription early in the year, since it turns a large upfront cost into smaller monthly payments through December.

If your income is limited, you may also qualify for Medicare's Extra Help program for 2026, which can reduce or eliminate your Part D deductible, premium, and copays, in some cases well below the standard $2,100 cap.

Where the Cap Fits Into Your Broader Medicare Costs

The $2,100 drug cap is one piece of what you'll pay for Medicare in 2026. It's worth reviewing alongside your Part B premium for 2026, since Part B and Part D premiums both rise, and both are subject to income-related surcharges if your reported income is above the IRMAA thresholds. Reviewing all three together, drug costs, Part B premiums, and any IRMAA add-on, gives you a realistic sense of your total Medicare spending for the year rather than looking at drug costs in isolation.